12/18/2007 - BioFlux 200 System Delivers Live Cell Imaging with Controlled Shear Flow
San Francisco, Calif. (December 18, 2007) – Fluxion Bioscience introduced its new BioFlux 200 system at the American Society for Cell Biology annual meeting this month. This second-generation system adds advanced capabilities and higher throughput for live cell imaging in applications such as cell adhesion and microbial biofilm studies.

10/20/2007 - Fluxion Biosciences Completes $7M Series B Financing
San Francisco, CA: Fluxion Biosciences, a privately held drug discovery tools company, announced that it has completed a Series B financing of $6.85 million. The funds, invested by Kodiak Venture Partners, Claremont Creek Ventures, and first round investors Life Science Angels and North Bay Angels, will enable Fluxion to accelerate development and commercialization of the company’s products addressing a range of applications in single-cell biology.

9/17/2007 - Fluxion Biosciences Appoints AutoMate Scientific as BioFlux System Distributor
SAN FRANCISCO--(BUSINESS WIRE)--Fluxion Biosciences, a leading developer of microfluidic systems for cellular analysis in life sciences research and drug discovery, today announced that it has signed a distribution agreement with AutoMate Scientific.

5/17/2007 - Fluxion Biosciences Receives $1.2M NIH Grant for Development of Drug Discovery Platform
SAN FRANCISCO--(BUSINESS WIRE)-- Fluxion Biosciences, a leading developer of microfluidic systems for cellular analysis in life sciences research and drug discovery, today announced that it has received a $1.

3/26/2007 - Fluxion Biosciences Launches BioFlux System for Automated Biofilm Analysis
SAN FRANCISCO--(BUSINESS WIRE)--Fluxion Biosciences today announced the commercial launch of its BioFlux platform, which provides automated biofilm analysis for disease research and drug discovery applications.